Chicago TribuneImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow
Print this article

Chimps dying from AIDS-like disease, study says

Chicago Tribune - July 22, 2009
William Mullen, Tribune staff reporter


A team of scientists, including two from Lincoln Park Zoo, studying the wild chimpanzee population in Tanzania's Gombe National Park, has discovered chimps falling ill and dying of an AIDS-like disease, a surprising finding that researchers hope could lead to new insights into the disease process and ultimately to a vaccine.

The study's results are being published in Thursday's edition of the British research journal Nature. The article reveals that Gombe chimps infected by certain strains of SIV [Simian Immunodeficiency Virus] can contract an AIDS-like disease. Infected Gombe chimps died 10 to 16 times more frequently during the study period than uninfected chimps.

The results overturn previous evidence that suggested that chimpanzees were immune from AIDS and that SIV virus infections in them were harmless. Researchers already knew that some wild chimpanzee populations had individuals infected with SIV from eating infected monkeys.

A strain of SIV at some point mutated to HIV [Human Immunodeficiency Virus] in wild chimps in Cameroon in West Africa, where it jumped into the human population when infected chimp meat was eaten by humans.

Over several years of surveillance, the study showed that 10 to 20 percent of the Gombe chimps were SIV-infected.

The knowledge that some SIV strains can cause AIDS-like disease in chimps is a unique opportunity, AIDS researchers say, to compare and contrast how the two closely-related viruses become disease-causing agents in two closely-related species -- chimps and humans. Being able to compare and contrast, they say, should speed up development of more effective AIDS therapies and vaccines.

"It is a pretty momentous study," Danny Douek, the chief of the human immunology section of the National Institutes of Health vaccine research center in Bethesda, Md. Douek is not a part of the Gombe project but he is looking for possible AIDS vaccines.

"You can regard the study as one that provides a missing link in the history of [the] HIV pandemic. If we identify the evolutionary adaptations, that opens us therapeutic avenues for HIV disease," he said.

Two Lincoln Park Zoo scientists, Elizabeth Lonsdorf and Dominic Travis, set up a survey to assess the general health problems of the Gombe chimps. They trained Gombe park biologists to systematically but non-invasively gather data by following individual animals a day at a time, noting those that seemed ill or slowed by injury, collecting fecal and urine samples they left behind.

The zoo also trained Gombe park veterinarians how to conduct thorough necropsies - animal autopsies - in the field when a chimp died. They took relevant tissue and fluid samples, put them in preservatives and sent them to Chicago for analysis by veterinary pathologists at the University of Illinois Veterinary School of Medicine.

Londorf's and Travis' chimpanzee health survey dove-tailed perfectly with a project already up and running at Gombe by University of Alabama at Birmingham AIDS researcher Beatrice Hahn, the principle author of the Nature article. She had been studying SIV-infected Gombe chimps for several years.

"Their roles were critical" in reaching the findings, said Hahn. "This long-term health monitoring system was all their idea. There is no other chimpanzee field site that has such a system."

The necropsies provided were also crucial, said Hahn. Without it, the study would not have been able to show how the SIV strain in the Gombe chimps caused the health declines, "so their contribution was essential" to the project.


090722
CT090702


Copyright © 2009 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .